Found: 40
Select item for more details and to access through your institution.
Radiopharmaceuticals for Treatment of Adrenocortical Carcinoma.
- Published in:
- Pharmaceuticals (14248247), 2024, v. 17, n. 1, p. 25, doi. 10.3390/ph17010025
- By:
- Publication type:
- Article
Targeting 11-Beta Hydroxylase With [131I]IMAZA: A Novel Approach for the Treatment of Advanced Adrenocortical Carcinoma.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. e1348, doi. 10.1210/clinem/dgab895
- By:
- Publication type:
- Article
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy—Do Different Software Solutions Deliver Comparable Results?
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1390, doi. 10.3390/jcm9051390
- By:
- Publication type:
- Article
Responsivity of the Striatal Dopamine System to Methylphenidate—A Within-Subject I-123-β-CIT-SPECT Study in Male Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
- Published in:
- Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.804730
- By:
- Publication type:
- Article
Klinische Bedeutung von neuroendokrinen Tumoren: Häufigkeit, Symptome, Diagnose und Stadien und prognostische Faktoren und deren Einfluss auf das Krankheitsmanagement.
- Published in:
- Die Radiologie, 2024, v. 64, n. 7, p. 536, doi. 10.1007/s00117-024-01315-y
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
- Published in:
- Journal of Nuclear Medicine Technology, 2023, v. 51, n. 1, p. 22, doi. 10.2967/jnmt.122.264904
- By:
- Publication type:
- Article
Peptide Receptor Radionuclide Therapy in Merkel Cell Carcinoma: A Comprehensive Review.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Lymphoma-Sink Effect in Marginal Zone Lymphoma Based on CXCR4-Targeted Molecular Imaging.
- Published in:
- Molecular Imaging & Biology, 2023, v. 25, n. 4, p. 758, doi. 10.1007/s11307-023-01830-9
- By:
- Publication type:
- Article
Impact of Tumor Burden on Normal Organ Distribution in Patients Imaged with CXCR4-Targeted [<sup>68</sup>Ga]Ga-PentixaFor PET/CT.
- Published in:
- Molecular Imaging & Biology, 2022, v. 24, n. 4, p. 659, doi. 10.1007/s11307-022-01717-1
- By:
- Publication type:
- Article
Dose-Escalated Salvage Radiotherapy for Macroscopic Local Recurrence of Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era.
- Published in:
- Cancers, 2022, v. 14, n. 19, p. 4956, doi. 10.3390/cancers14194956
- By:
- Publication type:
- Article
Changing Threshold-Based Segmentation Has No Relevant Impact on Semi-Quantification in the Context of Structured Reporting for PSMA-PET/CT.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 270, doi. 10.3390/cancers14020270
- By:
- Publication type:
- Article
Development of Discordant Hypermetabolic Prostate Cancer Lesions in the Course of [ 177 Lu]PSMA Radioligand Therapy and Their Possible Influence on Patient Outcome.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4270, doi. 10.3390/cancers13174270
- By:
- Publication type:
- Article
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266702
- By:
- Publication type:
- Article
Prognostic Performance of RECIP 1.0 Based on [<sup>18</sup>F]PSMA-1007 PET in Prostate Cancer Patients Treated with [<sup>177</sup>Lu]Lu-PSMA I&T.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 4, p. 560, doi. 10.2967/jnumed.123.266702
- By:
- Publication type:
- Article
Long-Term Nephrotoxicity of <sup>177</sup>Lu-PSMA Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 79, doi. 10.2967/jnumed.123.265986
- By:
- Publication type:
- Article
Chemokine Receptor PET/CT Provides Relevant Staging and Management Changes in Marginal Zone Lymphoma.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 12, p. 1889, doi. 10.2967/jnumed.123.266074
- By:
- Publication type:
- Article
CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1424, doi. 10.2967/jnumed.123.265464
- By:
- Publication type:
- Article
Elevated Body Mass Index Is Associated with Improved Overall Survival in Castration-Resistant Prostate Cancer Patients Undergoing Prostate-Specific Membrane Antigen--Directed Radioligand Therapy.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 8, p. 1272, doi. 10.2967/jnumed.122.265379
- By:
- Publication type:
- Article
Prognostic Value of Tumor Volume Assessment on PSMA PET After <sup>177</sup>Lu-PSMA Radioligand Therapy Evaluated by PSMA PET/CT Consensus Statement and RECIP 1.0.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 4, p. 605, doi. 10.2967/jnumed.122.264489
- By:
- Publication type:
- Article
Comparison of PET/CT-based eligibility according to VISION and TheraP trial criteria in end-stage prostate cancer patients undergoing radioligand therapy.
- Published in:
- Annals of Nuclear Medicine, 2024, v. 38, n. 2, p. 87, doi. 10.1007/s12149-023-01874-5
- By:
- Publication type:
- Article
Reduced Segmentation of Lesions Is Comparable to Whole-Body Segmentation for Response Assessment by PSMA PET/CT: Initial Experience with the Keyhole Approach.
- Published in:
- Biology (2079-7737), 2022, v. 11, n. 5, p. 660, doi. 10.3390/biology11050660
- By:
- Publication type:
- Article
CXCR4-Directed PET/CT in Patients with Newly Diagnosed Neuroendocrine Carcinomas.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 4, p. 605, doi. 10.3390/diagnostics11040605
- By:
- Publication type:
- Article
Complete loss of E-cadherin expression in a rare case of metastatic malignant meningioma: a case report.
- Published in:
- BMC Neurology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12883-023-03450-w
- By:
- Publication type:
- Article
Any decline in prostate‐specific antigen levels identifies survivors scheduled for prostate‐specific membrane antigen‐directed radioligand therapy.
- Published in:
- Prostate, 2022, v. 82, n. 14, p. 1406, doi. 10.1002/pros.24414
- By:
- Publication type:
- Article
Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid Cancer.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 10, p. 5493, doi. 10.3390/ijms25105493
- By:
- Publication type:
- Article
Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 12, p. 3643, doi. 10.1007/s00259-024-06800-z
- By:
- Publication type:
- Article
CXCR4-directed PET/CT with [<sup>68</sup> Ga]Ga-pentixafor in solid tumors—a comprehensive analysis of imaging findings and comparison with histopathology.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1383, doi. 10.1007/s00259-023-06547-z
- By:
- Publication type:
- Article
Chemokine receptor–targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [<sup>18</sup>F]FDG.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 3, p. 749, doi. 10.1007/s00259-023-06489-6
- By:
- Publication type:
- Article
Early biochemical and radiographic response after one cycle of [<sup>177</sup>Lu]Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3765, doi. 10.1007/s00259-023-06326-w
- By:
- Publication type:
- Article
SUV<sub>mean</sub> on baseline [<sup>18</sup>F]PSMA-1007 PET and clinical parameters are associated with survival in prostate cancer patients scheduled for [<sup>177</sup>Lu]Lu-PSMA I&T.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 11, p. 3465, doi. 10.1007/s00259-023-06281-6
- By:
- Publication type:
- Article
Molecular imaging of arterial fibroblast activation protein: association with calcified plaque burden and cardiovascular risk factors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 10, p. 3011, doi. 10.1007/s00259-023-06245-w
- By:
- Publication type:
- Article
CXCR4-targeted molecular imaging after severe SARS-Cov-2 infection.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
mCRPC patients with PSA fluctuations under radioligand therapy have comparable survival benefits relative to patients with sustained PSA decrease.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4727, doi. 10.1007/s00259-022-05910-w
- By:
- Publication type:
- Article
Baseline clinical characteristics predict overall survival in patients undergoing radioligand therapy with [<sup>177</sup>Lu]Lu-PSMA I&T during long-term follow-up.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4262, doi. 10.1007/s00259-022-05853-2
- By:
- Publication type:
- Article
Matched-pair analysis of [<sup>177</sup>Lu]Lu-PSMA I&T and [<sup>177</sup>Lu]Lu-PSMA-617 in patients with metastatic castration-resistant prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 9, p. 3269, doi. 10.1007/s00259-022-05744-6
- By:
- Publication type:
- Article
Novel CYP11B-ligand [<sup>123/131</sup>I]IMAZA as promising theranostic tool for adrenocortical tumors: comprehensive preclinical characterization and first clinical experience.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 49, n. 1, p. 301, doi. 10.1007/s00259-021-05477-y
- By:
- Publication type:
- Article
Intraindividual comparison of [<sup>177</sup>Lu]Lu-DOTA-EB-TATE and [<sup>177</sup>Lu]Lu-DOTA-TOC.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 8, p. 2566, doi. 10.1007/s00259-020-05177-z
- By:
- Publication type:
- Article
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 6, p. 2024, doi. 10.1007/s00259-020-05160-8
- By:
- Publication type:
- Article
Pitfalls in PSMA-PET/CT: intensive bone marrow uptake in a case with polycythemia vera.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 5, p. 1669, doi. 10.1007/s00259-020-05072-7
- By:
- Publication type:
- Article
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 8, p. 2044, doi. 10.1007/s00259-019-04645-5
- By:
- Publication type:
- Article